Ukrainian Doctor Explains How Revmastop Works and its Effect on the Stomach

Ukrainian Doctor Addresses Concerns About Stomach Irritation from Revmastop Kiev, Ukraine – May 22, 2025 – A recent video by Dr. Igor Bilik, an emergency and family medicine physician in Ukraine, has addressed concerns about the gastrointestinal effects of the medication Revmastop. The short video, uploaded on May 21st, has already garnered over 4000 views and numerous likes. Dr. Bilik explains that the drug's active compound, Meloxicam, is a selective COX-2 inhibitor. This means it targets inflammation-causing enzymes while largely sparing the enzymes that protect the stomach lining. "This selectivity," explains Dr. Bilik, "leads to a significantly lower risk of stomach ulcers and bleeding compared to other non-selective NSAIDs." The video serves as a response to a user's inquiry about the medication's potential harm to the stomach. Dr. Bilik's clear and concise explanation makes complex medical information accessible to a wider audience, highlighting the importance of understanding medication side effects. The video's popularity underscores the public's interest in reliable health information, particularly regarding common medications.